Concepedia

Katelyn Singh

KS

6

Publications

239

Citations

6

H-Index

2020

Active since

Affiliations

Yale University(Current)

Howard Hughes Medical Institute

Katelyn Singh is an author at Yale University specializing in immunology, autoimmune disease, and medicine.

ORCID

Top concepts

Publications per year

2020–2023

6

Publications

6

Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis

William Damsky, Alice Wang, Daniel Kim et al. · Nature Communications · 2022 · 108 citations · Full text

Innate type 2 immunity controls hair follicle commensalism by Demodex mites

Roberto R. Ricardo-González, Maya E. Kotas, Claire E. O’Leary et al. · Immunity · 2022 · 43 citations · Full text

Treatment of necrobiosis lipoidica with combination Janus kinase inhibition and intralesional corticosteroid

William Damsky, Katelyn Singh, Anjela Galan et al. · JAAD Case Reports · 2020 · 29 citations · Full text

, , +16

Immune checkpoint inhibitor-induced bullous pemphigoid is characterized by interleukin (IL)-4 and IL-13 expression and responds to dupilumab treatment

William Shipman, Katelyn Singh, Jeffrey M. Cohen et al. · British Journal of Dermatology · 2023 · 22 citations · Full text

, , +25

Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy

Katelyn Singh, Alice Wang, Peter Heald et al. · JAAD Case Reports · 2020 · 19 citations · Full text

Rows per page

1–5 of 6